Literature DB >> 2453466

Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages.

I E Flesch1, S H Kaufmann.   

Abstract

Bone marrow-derived murine macrophages are able to inhibit the growth of Mycobacterium bovis and of some strains of M. tuberculosis after stimulation with either recombinant gamma interferon (rIFN-gamma) or lymphokines from antigen-specific T-cell clones. To elucidate the mechanism(s) involved in antimycobacterial activity, macrophages were infected with M. bovis in the presence of agents thought to influence the antimicrobial effects of phagocytes. Scavengers of toxic oxygen metabolites failed to influence the capacity of IFN-gamma-activated bone marrow macrophages to inhibit the growth of M. bovis. Suramin slightly affected mycobacterial growth in IFN-gamma-activated macrophages, and chloroquine markedly induced growth inhibition of M. bovis in unstimulated macrophages. We conclude that growth inhibition of M. bovis by IFN-gamma-activated macrophages is an oxygen-independent process.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453466      PMCID: PMC259422          DOI: 10.1128/iai.56.6.1464-1469.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

2.  Manipulations of the phagosome-lysosome fusion response in cultured macrophages. Enhancement of fusion by chloroquine and other amines.

Authors:  P D Hart; M R Young
Journal:  Exp Cell Res       Date:  1978-07       Impact factor: 3.905

3.  Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.

Authors:  C D Rothermel; B Y Rubin; E A Jaffe; H W Murray
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

4.  The effect of inhibitors and enhancers of phagosome--lysosome fusion in cultured macrophages on the phagosome membranes of ingested yeasts.

Authors:  P D Hart; M R Young
Journal:  Exp Cell Res       Date:  1979-02       Impact factor: 3.905

Review 5.  Suramin: with special reference to onchocerciasis.

Authors:  F Hawking
Journal:  Adv Pharmacol Chemother       Date:  1978

Review 6.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

7.  Killing of Mycobacterium microti by immunologically activated macrophages.

Authors:  L Walker; D B Lowrie
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

8.  Growth requirements of murine bone marrow macrophages in serum-free cell culture.

Authors:  I Flesch; E Ferber
Journal:  Immunobiology       Date:  1986-03       Impact factor: 3.144

9.  The role of reactive oxygen metabolites in lymphocyte-mediated cytolysis.

Authors:  C J Bishop; C M Rzepczyk; D Stenzel; K Anderson
Journal:  J Cell Sci       Date:  1987-04       Impact factor: 5.285

10.  Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates.

Authors:  H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  32 in total

1.  Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).

Authors:  K Sato; T Akaki; H Tomioka
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

Review 2.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  Differential gene expression in response to adjunctive recombinant human interleukin-2 immunotherapy in multidrug-resistant tuberculosis patients.

Authors:  B J Johnson; I Estrada; Z Shen; S Ress; P Willcox; M J Colston; G Kaplan
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.

Authors:  R Appelberg; A M Sarmento
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

5.  Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.

Authors:  H M Surcel; H Syrjälä; R Karttunen; S Tapaninaho; E Herva
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 6.  Heat shock proteins and infection: interactions of pathogen and host.

Authors:  T R Garbe
Journal:  Experientia       Date:  1992-07-15

7.  Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.

Authors:  M Denis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 8.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

9.  In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation.

Authors:  R Appelberg; I M Orme; M I Pinto de Sousa; M T Silva
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 10.  Tactics of Mycobacterium avium subsp. paratuberculosis for intracellular survival in mononuclear phagocytes.

Authors:  Seng Ryong Woo; Charles J Czuprynski
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.